A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease

Recruiting

Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.

Trial locations(65 sites)

United States

Clinical Site, Anaheim, California

Clinical Site, Costa Mesa, California

Clinical Site, Lafayette, California

Clinical Site, Los Alamitos, California

Clinical Site, Newport Beach, California